Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AOK: Atropine and Orthokeratology for Myopia Control
NCT02955927Completed
- Sponsor
- The Hong Kong Polytechnic University
- Start
- Nov 2016
- Primary completion
- May 2021
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised, single-blind trial of NVK002 in myopia, sponsored by The Hong Kong Polytechnic University. Started Nov 2016; status: completed.
02
Drugs
NVK002
03
Conditions
myopia
Beyond the preview
Go deeper on NCT02955927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02955927.